Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Douthwaite, S.
Right arrow Articles by Champney, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Douthwaite, S.
Right arrow Articles by Champney, W. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 48, 1-8
© 2001 The British Society for Antimicrobial Chemotherapy

Supplement

Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site

Stephen Douthwaitea,* and W. Scott Champneyb

a Department of Biochemistry and Molecular Biology, Odense University, DK-5230 Odense M, Denmark; b East Tennessee State University, TN, USA

Abstract

Ketolides are the most recent generation of antimicrobials derived from the 14-membered ring macrolide, erythromycin A. The main structural feature that differentiates ketolides from erythromycin is the keto group, which replaces the L-cladinose moiety at position 3 of the macrolactone ring. The keto group bestows greater acid stability on the drugs, and enables them to bind to their ribosomal target without causing expression of MLSB resistance in inducible strains. Several ketolides are described here, including ABT 773 and telithromycin (HMR 3647), both of which possess a carbamate at C11/C12 of the macrolactone ring. In telithromycin, which is the first ketolide to be approved for clinical use, the carbamate is linked to an alkyl-aryl extension, which is responsible for the increased potency of this compound relative to macrolides. This review examines how the structural differences between macrolides and the new ketolides are related to their antimicrobial activities in inhibiting protein synthesis and blocking the assembly of new ribosomal subunits.

Notes

* Corresponding author. Tel: +45-6550-2395; Fax: +45-6593-2467; E-mail: srd{at}bmb.sdu.dk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
M.-I. Morosini, R. Canton, E. Loza, R. del Campo, F. Almaraz, and F. Baquero
Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin
J. Antimicrob. Chemother., July 1, 2003; 52(1): 50 - 55.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
I. Garcia, A. Pascual, S. Ballesta, C. del Castillo, and E. J. Perea
Accumulation and activity of cethromycin (ABT-773) within human polymorphonuclear leucocytes
J. Antimicrob. Chemother., July 1, 2003; 52(1): 24 - 28.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
G. Ackermann and A. C. Rodloff
Drugs of the 21st century: telithromycin (HMR 3647)--the first ketolide
J. Antimicrob. Chemother., March 1, 2003; 51(3): 497 - 511.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
G. P. Dinos, S. R. Connell, K. H. Nierhaus, and D. L. Kalpaxis
Erythromycin, Roxithromycin, and Clarithromycin: Use of Slow-Binding Kinetics to Compare Their in Vitro Interaction with a Bacterial Ribosomal Complex Active in Peptide Bond Formation
Mol. Pharmacol., March 1, 2003; 63(3): 617 - 623.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.